Failure to Complete Recommended Antipsychotic Movement-Disorder Monitoring
Penalty
Summary
The facility failed to ensure recommended monitoring for adverse effects of antipsychotic medication was completed for one resident receiving psychoactive medication. The resident was readmitted with multiple diagnoses, including bipolar disorder, anxiety disorder, and traumatic brain injury, and had a care plan directing staff to monitor and report side effects and adverse reactions related to psychoactive medications. A physician’s order documented that the resident was to receive Seroquel 300 mg by mouth once daily for traumatic brain injury. A pharmacy review noted that antipsychotic medications can cause tardive dyskinesia and other movement disorders and recommended that a movement-disorder assessment, such as an AIMS or DISCUS test, be completed at least every six months while the resident remained on antipsychotic therapy. Record review showed the last AIMS assessment was completed more than six months before the pharmacy recommendation and outside the recommended monitoring interval, and the DON confirmed that the pharmacy recommendation had not been acted upon and the record did not contain a current AIMS assessment.
We Help Long-Term Care Teams Stay Survey-Ready
We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.